NPPA irked by procedural lapse in SLP filing
The National Pharmaceutical Pricing Authority (NPPA), which had gone on record saying that the government will file a Special Leave Petition in the Supreme Court, is disturbed by the procedural lapses in filing the petition.
German Remedies to focus on respiratory business
German Remedies is reorganizing its product portfolio mix following the acquisition of 27.1 per cent stake by Zydus Cadila promoted Recon Healthcare.
TB drug makers refute rifampicin disintegration theory
The findings of two parallel studies conducted at National Institute of Pharmaceutical Education & Research (NIPER), Chandigarh and L M College of Pharmacy, Ahmedabad seem to have stirred up a hornets’ nest amongst the anti-TB drug manufacturers here.